<?xml version="1.0" encoding="UTF-8"?>
<ref id="B6-pharmaceuticals-13-00096">
 <label>6.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Alhazzani</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>MÃ¸ller</surname>
    <given-names>M.H.</given-names>
   </name>
   <name>
    <surname>Arabi</surname>
    <given-names>Y.M.</given-names>
   </name>
   <name>
    <surname>Loeb</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Gong</surname>
    <given-names>M.N.</given-names>
   </name>
   <name>
    <surname>Fan</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Oczkowski</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Levy</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Derde</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Dzierba</surname>
    <given-names>A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Surviving sepsis campaign: Guidelines on the management of critically ill adults with coronavirus disease</article-title>
  <source>Intensive Care Med.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1007/s00134-020-06022-5</pub-id>
 </element-citation>
</ref>
